- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0012295

Sri Karthikeya Bio & Pharma Projects Private Limited
About Sri Karthikeya Bio & Pharma Projects Private Limited
Data last updated:
Sri Karthikeya Bio & Pharma Projects Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33111TG2015PTC098912. Its GSTIN is 36AAVCS8180P1Z4 (Telangana).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹55 Lakh. It is led by directors Shivaram Prasad Golla and Veerla Saithirumal Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 93 Ground Floor Vijayanagar Colony Near Patelkunta Park, Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.22 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.32 Lakh (net margin 3.2%) and EBITDA of ₹72.13 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 20% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.53 Cr and satisfied charges of ₹80 Lakh on record.
Sri Karthikeya Bio & Pharma Projects Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0012295). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Sri Karthikeya Bio & Pharma Projects
Contact details
Sri Karthikeya Bio & Pharma Projects Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 – 22 – 93 Ground Floor Vijayanagar Colony Near Patelkunta Park Montessori School, Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sri Karthikeya Bio & Pharma Projects is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Financials of Sri Karthikeya Bio & Pharma Projects Private Limited
FY 2025 filings availableSri Karthikeya Bio & Pharma Projects Private Limited reported revenue of ₹10.22 Cr (up 222% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 222% growth in the latest year. EBITDA rose 290% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Board of directors of Sri Karthikeya Bio & Pharma Projects Private Limited
Sri Karthikeya Bio & Pharma Projects has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivaram Prasad Golla Also directs: Sri Monashi Life Sciences Private Limited | Director | 06 Aug 2015 | 11 Years 2 Months | Current |
| Veerla Saithirumal Rao Also directs: Sri Monashi Life Sciences Private Limited | Director | 13 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Sri Karthikeya Bio & Pharma Projects Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medwin Pharmaceuticals Private Limited | ₹10.29 Cr (FY 2025) | 19.0% | Aligarh, Uttar Pradesh, India | |||
| Elinor Healthcare Private Limited | ₹10.28 Cr (FY 2024) | 831.0% | Hyderabad, Telangana, India | |||
| Voizmed Pharma Private Limited | ₹10.24 Cr (FY 2024) | 23.0% | Panchkula, Haryana, India | |||
| Bestel Laboratories Private Limited | ₹10.23 Cr (FY 2025) | 31.0% | Anand, Gujarat, India | |||
| Sri Karthikeya Bio & Pharma Projects Private Limitedthis company | ₹10.22 Cr (FY 2025) | ₹32.32 Lakh | 3.2% | 222.0% | 23 | Hyderabad, Telangana, India |
| Floreat Medica Private Limited | ₹10.19 Cr (FY 2025) | 4.0% | Angamaly, Kerala, India |
To see the full peer comparison of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Auditor
Sri Karthikeya Bio & Pharma Projects Private Limited is audited by RAO RAJU & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAO RAJU & ASSOCIATES | FY 2023 | 011401S |
Shareholding
The shareholding of Sri Karthikeya Bio & Pharma Projects Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Oct 2020 | 100386610 | Hdfc Bank Limited | ₹21.12 Lakh | Open | |
| 13 Feb 2019 | 100244913 | Hdfc Bank Limited | ₹14.31 Cr | Open | |
| 20 Sep 2016 | 100051818 | Others | ₹80 Lakh | Satisfied |
To see the full charge records of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sri Karthikeya Bio & Pharma Projects Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sri Karthikeya Bio & Pharma Projects Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sri Karthikeya Bio & Pharma Projects Private Limited has a workforce of 23 employees on its EPFO records as of Oct 31, 2024, across 1 active EPFO establishment.
GST
Sri Karthikeya Bio & Pharma Projects has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAVCS8180P1Z4 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.
Recent activity
Sri Karthikeya Bio & Pharma Projects Private Limited has 10 board changes on record since 2015: 6 appointments and 4 cessations. The latest: Ahalya Pandillapalli ceased to be Director on 22 May 2023.
6 earlier events are in the company report.
Frequently asked questions
Sri Karthikeya Bio & Pharma Projects is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2015 (11+ years old) and is registered under CIN U33111TG2015PTC098912.
Sri Karthikeya Bio & Pharma Projects has 2 current directors:
- Shivaram Prasad Golla - Director
- Veerla Saithirumal Rao - Director
The latest financial statements of Sri Karthikeya Bio & Pharma Projects on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sri Karthikeya Bio & Pharma Projects is 36AAVCS8180P1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Sri Karthikeya Bio & Pharma Projects is U33111TG2015PTC098912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sri Karthikeya Bio & Pharma Projects was incorporated on 14 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sri Karthikeya Bio & Pharma Projects by revenue are Medwin Pharmaceuticals Private Limited, Elinor Healthcare Private Limited, Voizmed Pharma Private Limited, Bestel Laboratories Private Limited, Floreat Medica Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Ahalya Pandillapalli ceased to be Director on 22 May 2023. Rangineni Karthik ceased to be Director on 22 May 2023. Rachakonda Sai Ramakrishna Rao ceased to be Additional Director on 18 Oct 2021. Sri Karthikeya Bio & Pharma Projects has 10 board changes on record in total.
Yes, Sri Karthikeya Bio & Pharma Projects is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0012295).
The registered office of Sri Karthikeya Bio & Pharma Projects is at 2 – 22 – 93 Ground Floor Vijayanagar Colony Near Patelkunta Park Montessori School, Kukatpally, Hyderabad, Telangana, India – 500072.
Sri Karthikeya Bio & Pharma Projects operates in the pharma industry, in the drug formulation and development segment.